Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Welireg
Pharma
FDA signs off on Merck’s Welireg to treat adrenal system tumors
The FDA approved a third indication for Merck's Welireg, signing off on it as a treatment for a rare condition that causes adrenal system tumors.
Kevin Dunleavy
May 15, 2025 10:43am
Key drugs from Merck, Bayer and Gilead win EMA backing
Dec 13, 2024 10:33am
Merck's Welireg again comes up short in OS but excels in PFS
Sep 13, 2024 8:00am
FDA signs off on 2nd approval for Merck's Welireg
Dec 15, 2023 11:33am
At ESMO, Merck touts Welireg's potential in kidney cancer
Oct 21, 2023 9:00am
Merck looks to broaden Welireg's reach in kidney cancer
Aug 18, 2023 11:12am
